Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Insulin Delivery Devices Market Expected to Grow Between 2025 And 2029?

The market for insulin delivery devices has seen a robust growth in recent years. It is projected to rise from $17.71 billion in 2024 to $19.07 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be credited to the convenience and user-friendliness of these insulin delivery devices, positive reimbursement policies, a rise in obesity rates, a growing elderly population, and an increased uptake of insulin pumps.

The market for insulin delivery devices is projected to experience robust growth in the coming years, expanding to a value of $25.98 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. This increase in the forecast period is credited to the escalating prevalence of diabetes, higher diabetes care spending, the emergence of continuous glucose monitoring systems, heightened patient awareness of the advantages of automated insulin delivery devices, and a growing emphasis on healthcare. Notable trends over the forecast period encompass advancements in the technology of insulin delivery devices, assimilation of digital technology into these devices, progress in the production of artificial pancreas systems and advancements in insulin administration technology, along with bionic technology developments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

What Are the Core Market Drivers Propelling Growth in the Insulin Delivery Devices Industry?

The surge in diabetes incidents is predicted to propel insulin delivery devices’ market expansion in the future. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or the body’s inefficient use of insulin, is a long-term health concern. It has been observed that the rate of diabetes is escalating due to inactive lifestyles, unhealthy eating habits, and increasing global obesity rates. Insulin delivery devices are necessary for managing diabetes as these devices enable one to regulate blood sugar levels methodically and conveniently by delivering insulin, thus averting complications and promoting wellbeing. For instance, according to a forecast from the Centers for Disease Control and Prevention in December 2022, the number of children and young adults in the US with type 2 diabetes could see about a 700% increase by 2060, affecting around 220,000 individuals. Simultaneously, there could be an increase in type 1 diabetes diagnoses by nearly 65% among the same group. Consequently, the escalating incidents of diabetes are fueling the growth of the insulin delivery devices market.

How Is the Insulin Delivery Devices Market Segmented?

The insulin delivery devicesmarket covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Which Regions Are Driving the Next Phase of the Insulin Delivery Devices Market Growth?

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Insulin Delivery Devices Industry?

Leading companies in the insulin delivery devices market are creating advanced products like insulin pumps which facilitate continuous and customizable delivery of insulin. Insulin pumps are programmable health devices that administer insulin either continuously or when necessary through a catheter installed under the skin. For example, Beta Bionics, a medical tech company based in the US, announced in May 2023 that the iLet ACE Pump and the iLet Dosing Decision Software had been approved by the U.S. Food and Drug Administration. The iLet Bionic Pancreas system is formulated for people aged six and older with type 1 diabetes. It merges two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM) and uses an automated insulin dosing (AID) system powered by an adaptive closed-loop algorithm. This system does not require any manual adjustment of settings and it’s easier to start and manage. It also has a meal announcement feature that simplifies mealtime insulin dosing by classifying meals into small, medium, or large, and the algorithm adapts to individual insulin needs over time.

View the full report here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

How Is the Insulin Delivery Devices Market Defined and What Are Its Core Parameters?

Insulin delivery devices refer to medical tools designed to administer insulin into the body of a person with diabetes. These devices are crucial for managing blood glucose levels in individuals who cannot produce sufficient insulin naturally. These devices are used to manage blood sugar levels effectively, providing flexibility and convenience in insulin administration.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18642

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model